STVN Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: April 16, 2026
Report Source: 2025 Annual Report
Stevanato Group SpA. Stock Analysis STVN
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 6,010 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Read More Stevanato Group SpA (STVN) Chart
Key Statistics of Stevanato Group SpA (STVN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$17.67Volume
444.96KP/E Ratio (TTM)
29.5052 Week Range
Market Cap
4.97BAvg. Volume
653.59KDividend Yield
0.36%Financial Metrics & Statements of Stevanato Group SpA (STVN)
FAQ's for Stevanato Group SpA (STVN)
- According to Musaffa’s Shariah screening methodology, Stevanato Group SpA (STVN) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.